Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImpOCT: OCT1 Genotype and Metformin Tolerance
NCT02586636Phase 4Completed
- Sponsor
- NHS Tayside
- Start
- Mar 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by NHS Tayside. Started Mar 2016; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02586636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586636.